Healthcare & Pharmaceuticals

Published by
CorpWatch Blog
|
By |
Actavis, the world's third-largest generic drug manufacturer, has been sued by New York state to prevent it from forcing patients to take a new version of a popular Alzheimer's drug. The company is attempting to hook patients on an extended release version before its U.S. patent expires next year. Read More
Published by
CorpWatch Blog
|
By |
Three major pharmaceutical companies - AstraZeneca, Johnson & Johnson and Pfizer - have recently delayed or canceled clinical trials for testing tuberculosis (TB) drugs in India and South Africa. Activists say this is symbolic of a trend by Big Pharma to abandon research into diseases that affect poor people. Read More
Published by
CorpWatch Blog
|
By |
Bayer, the German pharmaceutical giant, is in hot water after CEO Marijn Dekkers told a Financial Times conference that the company designed medicines "for western patients who can afford it" not for the "Indian market." The company has been critical of the Indian governments efforts to make cheap generic drugs available locally. Read More
Published by
CorpWatch Blog
|
By |
U.S. corporations gave away $18.15 billion in charitable donations in 2012 - a combination of cash, grants, and in-kind goods - up 12.2 percent in nominal terms over the previous year. A closer look reveals profit motives, notably for pharmaceutical companies and retail chain Wal-Mart. Read More
Published by
CorpWatch Blog
|
By |
Myriad Genetics has lost its right to be the exclusive U.S. commercial provider of genetic screening tests for breast cancer or ovarian cancer. The American Civil Liberties Union (ACLU), which sued the company, claimed that the patent would limit scientific research as well as health care options for women. Read More
Published by
CorpWatch Blog
|
By |
All data on completed medical experiments are to be made available to the general public by GlaxoSmithKline, the biggest UK pharmaceutical company. The announcement is a major win for the AllTrials campaign mounted by healthcare activists as well as researchers that has gathered widespread support. Read More
* indicates required